Event Brief
May 12, 2026 at 7:05 AM ET
Hengrui signs up to $15.2 billion deal with BMS
By The BriefBrief
Jiangsu Hengrui Pharmaceutical signed a global collaboration and licensing agreement with Bristol Myers Squibb worth up to $15.2 billion.
WHO: Jiangsu Hengrui Pharmaceutical
WHAT: Signed a global collaboration and licensing agreement with Bristol Myers Squibb worth up to US$15.2 billion
WHEN: May 12, 2026 at 6:00 AM ET
WHERE: Jiangsu, China
WHY: To establish a global collaboration and licensing agreement with BMS.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Macron demands silence in Kenya, calls it disrespect
Emmanuel Macron
May 12, 2026 at 7:05 AM ET
Parents conceive to save daughter with thalassemia
Guangdong
May 12, 2026 at 7:05 AM ET
FBI questions CIA officers over Russia assessment probe
Fbi
May 12, 2026 at 7:05 AM ET
IRGC officer says Hormuz zone defined as larger
Iran
May 12, 2026 at 7:05 AM ET
Page 19272 of 21439
Same format. Every time.
Continue reading — sign in or create a free account with
